Sunday 12 July 2026

One To Watch

Affimed Therapeutics

Company Overview

Want to Update your Company's Profile?


Latest Affimed Therapeutics News

Away from ASH, but Affimed badly burnt
13 December 2022
Affimed partners with Artiva on combo therapies
3 November 2022
Affimed to focus AFM28 efforts outside USA
12 August 2022
T-cell lymphoma market predicted to be worth $1.8 billion by 2030
11 May 2022
More Affimed Therapeutics news >


Today's issue

The week in pharma: action, reaction and insight – week to July 10, 2026
Pharmaceutical
The week in pharma: action, reaction and insight – week to July 10, 2026
12 July 2026
Pharmaceutical
Bausch + Lomb ditches BL1107 in glaucoma after trial miss
11 July 2026
Biotechnology
Padcev-Keytruda wins broader FDA approval in bladder cancer
10 July 2026
Biotechnology
FDA thumbs up for Sanofi’s subcutaneous Sarclisa Escena
10 July 2026
Biotechnology
Hansoh reports positive Phase III China data for GSK-partnered Ris-Rez in small cell lung cancer
10 July 2026
Pharmaceutical
NMPA reviews QMS for regulation of vaccine and drug GMP compliance
10 July 2026
Pharmaceutical
Chronic hepatitis C cases set to edge higher across major markets through 2035, says GlobalData
10 July 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze